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Background: Falls are a leading cause of morbidity and mortality in older adults. Although numerous trials of falls
prevention interventions have been completed, there is extensive variation in their intervention components and
clinical context, such that the key elements of an effective falls prevention program remain unclear to patients,
clinicians, and policy-makers. Our objective is to identify the most effective interventions and combinations of
interventions that prevent falls though a systematic review and meta-analysis, including a network meta-analysis.
Methods/Design: We will search for published (e.g., MEDLINE, EMBASE, Cochrane Central Register of Controlled
Trials, Ageline) and unpublished (e.g., trial registries, dissertations) randomised clinical trials (RCTs) in all languages
examining interventions to prevent falls compared to usual care or other falls prevention interventions among
adults aged ≥65 years from all settings (e.g., community, acute care, long-term care, and rehabilitation). The primary
outcomes are number of injurious falls and number of hospitalizations due to falls. Secondary outcomes include
falls rate, number of fallers, number of emergency room visits due to falls, number of physician visits due to falls,
number of fractures, costs, and number of intervention-related harms (e.g., muscle soreness related to exercise).
We will calibrate our eligibility criteria amongst the team and two independent team members will screen the
literature search results in duplicate. Conflicts will be resolved through team discussion. A similar process will be
used for data abstraction and quality appraisal with the Cochrane risk of bias tool.
Our results will be synthesized descriptively and a random effects meta-analysis will be conducted if the studies are
deemed methodologically, clinically, and statistically (e.g., I2<60%) similar. If appropriate, a network meta-analysis
will be conducted, which will allow the comparison of interventions that have not been compared in head-to-head
RCTs, as well as the effectiveness of interventions.
Discussion: We will identify the most effective interventions and combinations of interventions that prevent falls in
older people. Our results will be used to optimize falls prevention strategies, and our goal is to ultimately improve
the health of seniors internationally.
Trial registration: PROSPERO registry number: CRD42013004151
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Falls (most commonly defined as “an unintentional/inad-
vertent/involuntary or accidental coming to rest on a
lower level”) [1] are a significant burden to society [2].
Each year, approximately 30% of community-dwelling
individuals aged 65 and older and 50% of community
dwellers aged 85 and older fall [3]. Seniors who fall are
two to three times more likely to fall again within one
year [4] and the incidence of falls will only increase in
the future, due to the growing proportion of older
people [5].
Falling can lead to anxiety, depression, social isolation,
and immobility. Of all community dwelling individuals
who fall, 12% to 42% will have a falls-related injury, with
up to 20% requiring medical attention and 10% resulting
in fracture secondary to osteoporosis [6]. Falls are the
underlying cause of 10-15% of all emergency room visits
for seniors [2] and account for 40% of all deaths due to
injury [7]. For falls that result in hospitalization, the
average cost is $30,000 CAD per senior [8].
Falls leading to hip fractures have the most devastating
prognosis [9]. One in 5 people who suffer a hip fracture
will die during the first year, and less than 1/3 will regain
their pre-fracture level of physical function [10]. Falls
leading to hip fracture are the most costly at $40,000
CAD per senior [8].
Although methodologically rigorous systematic re-
views have been conducted on falls prevention [11-14],
none have ranked all of the available interventions using
a network meta-analysis approach. As such, our object-
ive is to rank the efficacy of falls prevention interven-
tions across community, acute care, long-term care, and
rehabilitation settings through a systematic review and
network meta-analysis including published and unpub-
lished falls prevention randomised clinical trials (RCTs).
Our specific review question is: “In seniors aged ≥65
years living in acute care, community, long-term care
and rehabilitation settings, what are the most effective
falls prevention interventions (and combinations of in-
terventions) compared to usual care for reducing the
number of falls, physician visits, emergency room visits,
hospitalizations, and fractures due to falls?”.Methods/Design
We compiled a systematic review protocol using guid-
ance from the Preferred Reporting Items for Systematic
reviews and Meta-analyses Protocols (or PRISMA-P)
[15]. Our protocol was compiled, reviewed by the team,
and peer-reviewed by the Canadian Institutes of Health
Research knowledge synthesis committee. Our protocol
has been registered in the PROSPERO database
(CRD42013004151; available at: www.crd.york.ac.uk/
PROSPERO/display_record.asp?ID=CRD42013004151).Eligibility criteria
We will include RCTs (including all RCT designs such
as crossover, cluster and patient-randomised clinical tri-
als) examining falls prevention interventions amongst
adults aged ≥65 years from all settings (e.g., community,
acute care). Single and multifactorial interventions will
be included, such as exercise, gait and balance training,
vitamin D, vision correction, environmental assessment,
and medication review. The eligible comparators will in-
clude usual care or other falls prevention interventions.
In order to be included, the RCTs will have to examine
our primary or secondary outcomes of interest that have
been identified by the knowledge users involved with
this review. The primary outcomes of interest are the
number of injurious falls or number of hospital admis-
sions due to falls. Our secondary outcomes of interest
include falls rate, number of fallers, number of emer-
gency room visits due to falls, number of physician visits
due to falls, number of fractures, costs, and number of
intervention-related harms (e.g., muscle soreness or
myocardial infarction related to exercise).
Finally, we will not impose any language, time (i.e.,
studies of all duration will be included) or year of publi-
cation restrictions. Both published and unpublished ma-
terial will be included. A draft eligibility form is in
Appendix 1.
Information sources
We will start by searching electronic databases, such as
MEDLINE, EMBASE, Cochrane Central Register of
Controlled Trials, and Ageline. The main database
search will be supplemented with a comprehensive
search for grey literature; difficult to locate or unpub-
lished RCTs. It will be conducted using guidance from a
handbook produced by the Canadian Agency for Drugs
and Technology in Health (CADTH) on searching for
grey literature [16]. Specifically, we will search public
health websites (e.g., Health Canada, Public Health
Agency of Canada), organizations that produce clinical
practice guidelines (e.g., National Institute for Health
and Clinical Excellence, Agency for Healthcare Research
and Quality: www.guidelines.gov), clinical trial registers
(e.g., World Health Organization Clinical Trials Search
Portal: http://apps.who.int/trialsearch/, which allows
searching multiple databases simultaneously), and ab-
stracts and proceedings from meetings (e.g., Canadian
Geriatrics Society meetings, American Geriatrics Society
meetings, World Injury Prevention conferences). Fur-
thermore, forward citation searching for all included tri-
als will be conducted in Scopus, Web of Science and
Google. Experts in the field will be contacted via email
to identify relevant trials. Finally, the reference lists of
included trials and key studies identified through our
search will be searched.
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Comprehensive searches of the literature will be conducted
by our experienced librarian. The literature search will be
limited to adults and RCTs using validated filters. The draft
literature search for the main (MEDLINE) database will be
peer reviewed by another experienced librarian using the
Peer Review of Electronic Search Strategies (PRESS) check-
list [17]. After this exercise, the literature search will be
modified as necessary. The draft literature search for
MEDLINE can be found in Appendix 2.
Study selection process
To ensure reliability, a training exercise will be conducted
prior to screening. Using the inclusion and exclusion cri-
teria developed a priori, a random sample of 50 citations
from the literature search will be screened by all team
members independently using our online Synthesi.SR
Tool (proprietary online systematic review software devel-
oped for our Knowledge Synthesis Center at St. Michael’s
Hospital). Inter-rater agreement for study inclusion will be
calculated using percent agreement and a second training
exercise will be conducted if <95% agreement is observed.
When sufficient agreement has been reached, two re-
viewers will independently screen the citations from the
literature search results for inclusion in duplicate. Con-
flicts will be resolved through team discussion. Two re-
viewers will independently review the full-text of
potentially relevant articles to determine inclusion using a
similar process, except that authors are sometimes
contacted at this stage if study eligibility is unclear.
Data items
From the included RCTs, we will abstract data on study
characteristics (e.g., year of conduct, sample size, setting,
intervention and comparator), participant characteristics
(e.g., number of patients, mean age and standard devi-
ation, co-morbidities), primary outcomes results (injuri-
ous falls, hospital admissions due to falls), and secondary
outcomes results (falls rate, number of fallers, fractures,
emergency room and physician visits due to falls,
intervention-related harms, costs). We will abstract data
on the primary and secondary outcomes from each time
period reported across the RCTs to examine the effects
of the interventions on the outcomes over time. Multiple
study publications reporting data from the same study
group (i.e., companion reports) will be sorted and ab-
straction will only be conducted on the RCT reporting
the primary outcome of interest and/or longest duration
of follow-up. Sufficient data will be collected to allow
careful judgment of the homogeneity and similarity of
assumptions for meta-analysis, as described in the syn-
thesis section below.
Falls prevention strategies are complex interventions,
which are rarely reported in the literature [18]. As such,the authors of the included RCTs will be contacted to
obtain pertinent information, including details on the
population and setting, the intervention (e.g., ‘dose’, ‘for-
mulation’, schedule, timing of the intervention and moni-
toring), and how the intervention was delivered. We will
ask them to send us any training materials used for the
intervention. Authors will also be contacted for data
clarifications related to the primary and secondary out-
comes, as required.
Data collection process
The data abstraction form will be piloted on a random
sample of 10 included trials and modified as required.
Data abstraction will only begin when sufficient agree-
ment is noted (i.e., >95% agreement). Two reviewers will
independently abstract all of the data using the standard-
ized data abstraction form. All data abstraction will be
conducted using our online Synthesi.SR Tool, which
provides a summary of conflicts between reviewers and
allows these to be rectified directly in the system.
Discrepancies will be resolved by discussion amongst
the team.
Risk of bias appraisal
We will appraise the risk of bias using the Cochrane
Risk of Bias Tool [19]. This tool was developed specific-
ally to assess the internal validity of RCTs. It consists of
the following seven criteria: 1) randomization gener-
ation, 2) allocation concealment, 3) blinding of outcome
assessors, 4) blinding patients and personnel, 5) incom-
plete outcome data (i.e., withdrawals), 6) selective out-
come reporting, and 7) other risks of bias. The final
item will include fraudulent results, other methodo-
logical flaws in the RCTs, and the potential for industry
bias [20].
Synthesis of included studies
The results will first be synthesized descriptively,
reporting study characteristics, patient characteristics,
risk of bias results, and frequencies of outcomes across
the included RCTs. Prior to undertaking meta-analysis,
we will assess for statistical, clinical, and methodological
heterogeneity. If extensive statistical heterogeneity is ob-
served (e.g., I2 statistic > 60%) or if substantial clinical or
methodological heterogeneity is noted (based on the
team’s clinical and methodological expertise), we will
conduct meta-regression analysis. The meta-regression
will explore the influence of factors including baseline
effect sizes [source of statistical heterogeneity]; age,
frailty, comorbidities, setting (e.g., rehabilitation, com-
munity) [sources of clinical heterogeneity]; and trial de-
sign [source of methodological heterogeneity] on the
meta-analysis results. We will explore the effects of
sources of clinical and methodological heterogeneity on
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may explore include risk of bias (high versus low), attri-
tion rate (<10% versus ≥10%), and setting (e.g., acute
care, community, long-term care and rehabilitation set-
tings). We will use established methods for adjusting
cluster-randomised clinical trials for meta-analysis with
patient-randomised clinical trials [21,22]. For crossover
trials, we will include the data from the period before
the cross over was completed. Both meta-analysis and
meta-regression will be analyzed using SAS version 9.2.
Missing data from the included RCTs (e.g., unreported
standard deviations or standard errors) will be included in
our analysis using established imputation methods [23].
Although the assumptions underlying network meta-
analysis are similar to standard meta-analysis techniques,
there are additional issues of comparability that need to
be considered [24]. For example, the included studies
should be homogeneous across patient populations,
study design, and methodological characteristics. Fur-
thermore, the effect of all treatments included in the
model should be generalizable across all included studies
to ensure validity of results. If deemed feasible and ap-
propriate, network meta-analysis will be conducted to
derive the combined outcome for all possible pairwise
comparisons between interventions, including those that
were not directly compared within an RCT, as well as
rank the efficacy and safety among all available interven-
tions [25-27]. To examine the additive effects of multi-
factorial interventions, an additive mixed treatment
comparison with covariates will be conducted [28]. The
covariates will be coded as binary (yes/no or 1/0). For
example, a trial comparing exercise, balance assessment,
and medication reconciliation versus no intervention
will be coded as 1,1,1, versus 0,0,0. This approach can
tease out the effectiveness of single component interven-
tions compared to multifactorial interventions [28].
The consistency of the results from direct evidence
(i.e., head-to-head trials from pairwise meta-analysis)
versus indirect evidence (i.e., from network meta-
analysis) will be compared using the “node-splitting”
method. This method separates trial-level evidence for a
particular comparison (or node) by ‘direct’ and ‘indirect’
and the results are compared [29]. To facilitate the prac-
ticality of treatment comparisons, median rankings will
be used as point estimates of intervention efficacy and
safety. We will also use the graphic method proposed by
Salanti et al. to assist in the interpretation of the results
from the network meta-analysis [30]. Mixed treatment
meta-regression will be performed to examine the influ-
ence of study level covariates using the method pro-
posed by Nixon et al. [31]. The network meta-analysis
will be conducted in WinBUGS; [25] a Bayesian software
program used to build complex statistical models using
the Markov Chain Monte Carlo simulation. To distinguishbetween significant and non-significant treatment effica-
cies, 95% credible intervals will be established using the
2.5 and 97.5 percentiles obtained via Markov Chain
Monte Carlo simulation of 100,000 iterations. The 95%
credible interval will be interpreted in a similar manner as
confidence intervals are interpreted when they are derived
using standard meta-analysis methods [25]. Sensitivity
analysis will be conducted to examine the effects of impu-
tations for missing data [32], and the use of different
“priors” that were employed in the Bayesian network
meta-analysis.
Discussion
Our systematic review results have the potential to influ-
ence a large proportion of the population. Approximately
13% of Canadians are aged 65 or older and of these, 30%
fall every year. Due to our aging population, the number of
people falling is expected to increase. Furthermore, falling
is associated with a decreased quality of life, significant
morbidity, an increased risk of more falls, and can lead to
disability and ultimately death. It is a substantial burden on
family, caregivers, healthcare providers, the healthcare sys-
tem, and society. As such, understanding the most effective
falls prevention strategies, including the best combinations
of interventions is imperative.
We will ensure that our results have a positive impact on
the health outcomes of seniors, as well as their families and
caregivers using integrated knowledge translation and a var-
iety of end-of-grant knowledge translation strategies. Such
strategies include peer-reviewed publications, conference
presentations, dissemination to local, provincial, national,
and international policy-makers, and creating executive
summaries tailored and disseminated to different stake-
holder groups, including policy-makers, healthcare admin-
istrators, clinicians, and patients. Finally, we will hold a
dissemination meeting including key national stakeholders
(e.g., researchers, policy makers, healthcare providers) to
discuss the meaning and implications of the systematic re-
view. This will ensure the successful uptake of our results,
improving the health of seniors at risk of falling, as well as
their families and caregivers.
Appendix 1: draft eligibility criteria
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→ If you answer NO to any of these questions, the cit-
ation/study will be excluded. All other citations/studies
will be included. We will keep track of reviews that have
potentially relevant material and will scan their reference
lists to ensure all studies have been captured.
Level 2 screening










3. Is the falls prevention intervention being compared








5. Does this study report any of the relevant outcomes
(falls rate, number of fallers, number of injurious falls,
number of emergency room visits due to falls, number
of hospital admissions due to falls, number of physician





→ If you answer NO to any of these questions, the cit-
ation/study will be excluded. All other citations/studies
will be included. We will keep track of reviews that have
potentially relevant material and will scan their reference
lists to ensure all studies have been captured.
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